The INTERCEPT Blood System for Plasma and Platelets is approved in Canada
The INTERCEPT Blood System for plasma is intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma. The INTERCEPT Blood System for platelets is intended for the ex vivo treatment and storage of platelet components. The system is used to inactivate a broad range of pathogens, including viruses, bacteria, and protozoan parasites, thus reducing the risk of transfusion-transmitted infections (TTI).
Press Releases
Package Inserts
- Download the INTERCEPT Blood System for Plasma package insert
- Download the INTERCEPT Blood System for Platelets – Dual Storage (DS) package insert
- Download the INTERCEPT Blood System for Platelets – Large Volume (LV) package insert
- Download the INTERCEPT Blood System for Platelets – Small Volume (SV) package insert
Contact Us
Phone: 1.855.835.3523
Email: customerservices.americas@cerus.com